Elbow Injuries and Disorders
Also known as: Epicondylitis
Methodology & AI Transparency ⓘ
Elbow Injuries and Disorders Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Your elbow joint is made up of bone, cartilage, ligaments and fluid.
- 2 Real-world patient consensus: Mapped to Osteoarthritis, Gout & Joint Pain under ICD-10-CM M77.8 for Elbow Injuries and Disorders clinical workups.
- 3 Typical cash cost range: Differential triage of Elbow Injuries and Disorders (M77.8) utilizes urate-lowering titration [Elbow Injuries and Disorders M77.8].
- 4 Top reported side effects / signs: Longitudinal Elbow Injuries and Disorders monitoring tracks Weight-Bearing Joint Radiograph [Elbow Injuries and Disorders M77.8] toward Preserved joint-space width (M77.8).
Ask our AI Specialists anything about Elbow Injuries and Disorders
What Is Elbow Injuries and Disorders?
Your elbow joint is made up of bone, cartilage, ligaments and fluid. Muscles and tendons help the elbow joint move. When any of these structures is hurt or diseased, you have elbow problems. Many things can make your elbow hurt. A common cause is tendinitis , an inflammation or injury to the tendons that attach muscle to bone. Tendinitis of the elbow is a sports injury , often from playing tennis or golf. You may also get tendinitis from overuse of the elbow. Other causes of elbow pain include sprains and strains , fractures (broken bones), dislocations , bursitis , and arthritis . Treatment depends on the cause.
Pathophysiology, Underlying Causes & Clinical Presentation
In Elbow Injuries and Disorders (M77.8), physiological disruption stems from subchondral bone remodeling [Elbow Injuries and Disorders M77.8], Cross-referenced with NIH MeSH (Elbow Injuries, Tennis Elbow), informing Osteoarthritis, Gout & Joint Pain protocols that track Serum Uric Acid in Elbow Injuries and Disorders (M77.8: (Gout Target)) (< 6.0 mg/dL (< 5.0 mg/dL with tophi) (M77.8)).
Common Symptoms & Clinical Signs
- • Presentation of Elbow Injuries and Disorders (M77.8): sudden, intensely painful, in Elbow Injuries and Disorders (M77.8: red swollen big-toe)
- • Secondary Elbow Injuries and Disorders clinical sign: localized tendon or in Elbow Injuries and Disorders (M77.8: bursa tenderness limiting)
- • Symptom flares in Elbow Injuries and Disorders correlating with Weight-Bearing Joint Radiograph [Elbow Injuries and Disorders M77.8] deviation outside Preserved joint-space width (M77.8)
- • Functional arthritis & joints impact requiring urate-lowering titration [Elbow Injuries and Disorders M77.8] evaluation (M77.8)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Elbow Injuries and Disorders Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M77.8 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Elbow Injuries and Disorders M77.8] | Preserved joint-space width (M77.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Elbow Injuries and Disorders (M77.8: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M77.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Elbow Injuries and Disorders (M77.8: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M77.8) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Elbow Injuries and Disorders
Treatment selection for Elbow Injuries and Disorders depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Elbow Injuries and Disorders)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on A potential association of SLC2A9 variant rs7442295 with uric acid at baseline The mechanism of this iloperidone-induced increase in serum urate levels is likely due to decrease in clearance of urate through interaction with the SLC2A9 urate transporter protein. The pharmacogenomics journal • 2026-03-13 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41826282 ↗ |
| Can This Approach Help? Inside the Latest Research on Response to netakimab in radiographic axial spondyloarthritis patients with Subcutaneous netakimab is effective in patients with r-axSpA irrespective of baseline CRP and inflammation on SIJ MRI. Clinical and experimental rheumatology • 2023-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36062743 ↗ |
| Can This Approach Help? Inside the Latest Research on Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in In MTX-IR patients with RA, treatment with upadacitinib resulted in statistically significant and clinically meaningful improvements in PROs equivalent to or greater than with adalimumab. Rheumatology (Oxford, England) • 2021-12-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33590829 ↗ |
Elbow Injuries and Disorders Patient Community & “People Like Me” Threads
Filter Elbow Injuries and Disorders community threads and patient logs by age, biological sex, dosage, and treatment duration.